DFE Pharma’s CEO Martti Hedman discusses the partnership established by DFE Pharma, Harro Höfliger, and Sterling, in the field of dry powder inhalation.
Includes a multimillion-dollar investment to expand Corning’s Valor Glass technology to enable advanced injectable drug packaging and delivery systems.
Enhances the company's experience in producing lipids, one of the critical components for the formulation of mRNA therapeutics including Covid-19 vaccines.
This webcast will outline the typical steps Oakwood Labs takes during post-feasibility, scale-up, technology transfer, and Phase I clinical batch production.
State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.
A revolution has taken place in the process for producing Lipid Nano Particles suitable for drug products such as vaccines. Learn more in this Aug 10 webinar.
Vetter can help you identify and develop the right packaging strategies for your compound, from clinical dev to commercialization to life cycle management.
Vetter’s decades of experience as a contract manufacturer providing fill & finish for injectable drugs helps deliver results for both large and small companies.
Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.